Lumida
/ADUS
⌘K
Addus Homecare Corp

Addus Homecare Corp

ADUS
$114.52USD+0.62%+0.70 today

MARKET CAP

2.1B

P/E (TTM)

17.8x

FWD P/E

15.7x

DAY RANGE

$113 – $117

52W RANGE

$88
$124

AI Summary

Stalk
StalkMedium

ADUS is in a Stage 2 advancing uptrend with a clear HH/HL sequence and rising EMAs under price, but recent exhaustion signals and extreme overbought conditions make timing unfavorable. Under Growth at Reasonable Price discipline, defer buying and stalk for a pullback into the rising EMA support zone.

  • Q1 2026 revenue $363.6M (+7.7% YoY), led by personal care
  • Adjusted EPS $1.62 (+14.1% YoY) signals strong earnings growth
  • Proposed 6.4% Medicare home health cut could slash revenue
Full analysis →

The case for & against

Bull & Bear analysis

Bearish

Addis Home Care Corporation (NASDAQ: ADIS) is a leading provider in the home care services sector, specializing in personal care, hospice, and home health services. The company is well-positioned to benefit from an aging demographic and a growing preference for home-based care solutions, supported by regulatory shifts favoring increased reimbursement rates. Its strategic focus on acquisitions allows it to expand its geographic footprint, particularly in key markets like Illinois and Texas, while emphasizing operational efficiencies and quality care delivery.

Bull says

  • Q1 2026 revenue $363.6M (+7.7% YoY), led by personal care
  • Adjusted EPS $1.62 (+14.1% YoY) signals strong earnings growth
  • IL +3.9% and TX +9.9% Medicaid rates to boost ~$35M revenue
  • $52.4M operating cash flow funds strategic acquisitions
  • Gross margin stable at 31.9%; same-store personal care +6.5%
  • High earnings yield and strong profitability/momentum factors

Bear says

  • Proposed 6.4% Medicare home health cut could slash revenue
  • Clinical staffing constraints limit capacity amid tight labor market
  • Low dividend yield and 13F ownership signal weak investor support
  • Rapid acquisitions pose integration and synergy execution risks
  • Indiana entry faces pricing competition, risking margin compression
  • Small scale and quality concerns raise competitive and health risks

Investment themes with ADUS

Health Care Providers -0.61%

UNH · CVS · HCA

Earnings Call · Q1 2026 · Mgmt. Guidance

Updated 05-09-2026neutral

Transcript signals

Bull points

  • In Q1, we saw our margins really where we want them to be, and so our focus is now on volume.
  • In fact, in Q1 2026, new admissions, total volume, and total visits all improved sequentially versus Q4 2025. So that is the trend that we would like to see.
  • we've seen those rates exceed 25%. And we've also now begun that program in Illinois. Obviously, Illinois Home Health is a little bit earlier for us, but there is great opportunity there and opportunity to continue that pattern.

Bear points

  • I think we had guided people to think that's probably not long-term sustainable.
  • this year in this cycle, we're back to kind of a, you know, three-ish percent kind of default rate there.
  • Organic revenue declined 6.6%.
Read full transcript analysis ›